Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Open accessAbstract
Depression is one of the most common mood disorders with a high rate of relapse. Accumulating evidence suggests that the transcription factor Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated protein 1 (Keap1)- Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) system plays a key role in inflammation which is involved in depression. Preclinical studies demonstrated that the protein expressions of Keap1 and Nrf2 in the prefrontal cortex (PFC), CA3 and dentate gyrus (DG) of hippocampus in mice with depression-like phenotype were lower than control mice. In the learned helplessness paradigm, the protein levels of Keap1 and Nrf2 in the PFC and DG of hippocampus from rats with depression-like phenotype were also lower than control and resilient rats. Furthermore, rodents with depression-like phenotype have higher levels of pro-inflammatory cytokines. Interestingly, Nrf2 knock-out (KO) mice exhibit depression-like phenotype, and higher serum levels of pro-inflammatory cytokines compared with wild-type mice. Furthermore, Nrf2 KO mice have lower expression of brain-derived neurotrophic factor (BDNF) in the PFC, and CA3 and DG of hippocampus compared to wild-type mice. 7,8-Dihydroxyflavone, a TrkB agonist, showed antidepressant effects in Nrf2 KO mice, by stimulating BDNF-TrkB in the PFC, CA3 and DG. Pretreatment with sulforaphane, a naturally occurring Nrf2 activator, prevented depression-like phenotype in mice after inflammation or chronic social defeat stress. Interestingly, dietary intake of 0.1% glucoraphanin (a precursor of sulforaphane) containing food during juvenile and adolescent stages of mice could prevent depression-like phenotype in adulthood after chronic social defeat stress. Moreover, the protein expressions of Keap1 and Nrf2 in the parietal cortex from major depressive disorder and bipolar disorder were lower than controls. These findings suggest that Keap1-Nrf2 system plays a key role in the stress resilience which is involved in the pathophysiology of mood disorders. It is, therefore, possible that dietary intake of cruciferous vegetables including glucoraphanin (or SFN) may prevent or minimize relapse from remission, induced by stress and/or inflammation in depressed patients. In the review, the author would like to discuss the role of Keap1-Nrf2 system in mood disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increasing preclinical and clinical evidence suggests that higher levels of oxidative stress, alterations in the Keap1-Nrf2 pathway, and Nrf2-associated inflammation are involved in the pathogenesis of psychiatric disorders.
“however, increasing preclinical and clinical evidence suggests that higher levels of oxidative stress, alterations in the Keap1-Nrf2 pathway, and Nrf2-associated inflammation are involved in the pathogenesis of these psychiatric disorders [128,129,130,131,132].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu121 · Cited by 103 · see citing works
RetractedMolecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · see citing works
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903 · see citing works
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · see citing works
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · see citing works
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,570 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217 · see citing works
Why do many psychiatric disorders emerge during adolescence?
Paus, T., Keshavan, M., & Giedd, J. N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2513 · Cited by 3,123 · see citing works
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · see citing works
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · see citing works
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968 · see citing works
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682 · see citing works
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3820 · Cited by 1,613 · see citing works
A standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581 · see citing works
Fahey, J. W., Zhang, Y., & Talalay, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10367 · Cited by 1,380 · see citing works
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · see citing works
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways
Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150014 · Cited by 1,200 · cited 1× · see citing works
“Importantly, the Keap1-Nrf2 system plays a role in inflammation-associated pathogenesis (Kobayashi et al., 2013; Suzuki et al., 2013a; O’Connell and Hayes, 2015; Suzuki and Yamamoto, 2015; Wardyn et al., 2015; Yamamoto et al., 2018).”
BackgroundHaapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129 · see citing works
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M. P., Christ‐Schmidt, H., Goldsberry, A., Houser, M. T., Krauth, M., Heerspink, H. J. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,041 · see citing works
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995 · see citing works
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890 · see citing works
Correll, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0623 · Cited by 826 · see citing works
Lai, J. S., Hiles, S., Bisquera, A., Hure, A. J., McEvoy, M., & Attia, J. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069880 · Cited by 786 · see citing works
Toward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · see citing works
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · see citing works
Singh, A., Venkannagari, S., Oh, K. H., Zhang, Y., Rohde, J. M., Liu, L., Nimmagadda, S., Sudini, K. R., Brimacombe, K. R., Gajghate, S., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00651 · Cited by 624 · see citing works
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609 · see citing works
Nutritional medicine as mainstream in psychiatry
Sarris, J., Logan, A. C., Akbaraly, T. N., Amminger, G. P., Balanzá-Martínez, V., Freeman, M. P., Hibbeln, J., Matsuoka, Y., Mischoulon, D., Mizoue, T., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00051-0 · Cited by 592 · see citing works
Zhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538 · see citing works
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530 · see citing works
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522 · see citing works
Shelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511 · see citing works
Sulforaphane treatment of autism spectrum disorder (ASD)
Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416940111 · Cited by 449 · see citing works
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449 · see citing works
A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder
Young, J. J., Bruno, D., & Pomara, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.032 · Cited by 422 · see citing works
Hashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388 · see citing works
Emerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381 · see citing works
Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J., Chen, T.-Y., Fahey, J. W., & Talalay, P. (2012) · Topics in current chemistry · doi:10.1007/128_2012_339 · Cited by 363 · see citing works
Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M. P., Cho, H., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7759com · Cited by 340 · see citing works
Targeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 306 · see citing works
Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu077 · Cited by 289 · see citing works
Fruit and vegetable consumption and the risk of depression: A meta-analysis
Liu, X., Yan, Y., Li, F., & Zhang, D. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.009 · Cited by 287 · see citing works
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression
Bouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J.-H., Cresto, N., Doligez, N., Rivat, C., Do, K. Q., Bernard, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.144 · Cited by 248 · see citing works
Opie, R. S., O’Neil, A., Itsiopoulos, C., & Jacka, F. N. (2015) · Public Health Nutrition · doi:10.1017/s1368980014002614 · Cited by 243 · see citing works
Zhou, S.-F., Wang, Y., Zhe, H., Yang, Y., & He, Z. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s68872 · Cited by 230 · see citing works
Saghafian, F., Malmir, H., Saneei, P., Milajerdi, A., Larijani, B., & Esmaillzadeh, A. (2018) · British Journal of Nutrition · doi:10.1017/s0007114518000697 · Cited by 215 · see citing works
Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 208 · see citing works
Mills, E., Ogrodnik, M., Plave, A., & Mao-Draayer, Y. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00005 · Cited by 187 · see citing works
Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., & Hashimoto, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4062-3 · Cited by 183 · see citing works
Yang, B., Ren, Q., Zhang, J.-C., Chen, Q.-X., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.95 · Cited by 182 · see citing works
Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.112 · Cited by 182 · see citing works
Fahey, J. W., Holtzclaw, W. D., Wehage, S. L., Wade, K. L., Stephenson, K. K., & Talalay, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140963 · Cited by 174 · see citing works
Raison, C. L., Lowry, C. A., & Rook, G. A. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.161 · Cited by 169 · see citing works
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Tsuchida, K., Tsujita, T., Hayashi, M., Ojima, A., Keleku-Lukwete, N., Katsuoka, F., Otsuki, A., Kikuchi, H., Oshima, Y., Suzuki, M., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.041 · Cited by 167 · see citing works
Neuropathology of mood disorders: Do we see the stigmata of inflammation?
Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165 · see citing works
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
O'Connell, M. A., & Hayes, J. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150069 · Cited by 163 · see citing works
Yao, W., Zhang, J.-C., Ishima, T., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Suganuma, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30659 · Cited by 154 · see citing works
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152 · see citing works
Dietary Intake and Depressive Symptoms: A Systematic Review of Observational Studies
Murakami, K., & Sasaki, S. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900157 · Cited by 148 · see citing works
Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143 · see citing works
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 138 · see citing works
El‐Behadli, A. F., Sharp, C., Hughes, S. O., Obasi, E. M., & Nicklas, T. A. (2015) · British Journal Of Nutrition · doi:10.1017/s000711451400333x · Cited by 129 · see citing works
Jia, J., Wei, C., Liang, J., Zhou, A., Zuo, X., Song, H., Wu, L., Chen, X., Chen, S., Zhang, J., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.04.010 · Cited by 125 · see citing works
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 123 · see citing works
Mendez‐David, I., Tritschler, L., Ali, Z. E., Damiens, M.-H., Pallardy, M. J., David, D. J. P., Kerdine‐Römer, S., & Gardier, A. M. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.036 · Cited by 116 · see citing works
Targeting of NMDA receptors in new treatments for schizophrenia
Hashimoto, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.934225 · Cited by 115 · see citing works
A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives
Abdoulaye, I. A., & Guo, Y. J. (2016) · BioMed Research International · doi:10.1155/2016/5012341 · Cited by 115 · see citing works
Zhang, J., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Ushida, Y., Suganuma, H., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.004 · Cited by 113 · see citing works
Lu, X., & Dwyer, D. S. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:043 · Cited by 112 · see citing works
Dean, B., Tawadros, N., Scarr, E., & Gibbons, A. S. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.027 · Cited by 110 · see citing works
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador‐Woodruff, J. H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.239 · Cited by 110 · see citing works
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
Shiina, A., Kanahara, N., Sasaki, T., Oda, Y., Hashimoto, T., Hasegawa, T., Yoshida, T., Iyo, M., & Hashimoto, K. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.62 · Cited by 107 · see citing works
An Exceptionally Potent Inducer of Cytoprotective Enzymes
Dinkova‐Kostova, A. T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W. D., Wang, X. J., David, E., Schiavoni, K. H., Finlayson, S. D., Mierke, D. F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163485 · Cited by 106 · see citing works
Roles Nrf2 Plays in Myeloid Cells and Related Disorders
Kobayashi, E. H., Suzuki, T., & Yamamoto, M. P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/529219 · Cited by 94 · see citing works
Shirai, Y., Fujita, Y., Hashimoto, R., Ohi, K., Yamamori, H., Yasuda, Y., Ishima, T., Suganuma, H., Ushida, Y., Takeda, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127244 · Cited by 88 · see citing works
Polyunsaturated Fatty Acids in Perinatal Depression: A Systematic Review and Meta-analysis
Lin, P., Chang, C., Chong, M. F., Chen, H., & Su, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1182 · Cited by 88 · see citing works
Al‐Jaderi, Z., & Maghazachi, A. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00278 · Cited by 84 · see citing works
Hsu, M., Tung, C.-Y., & Chen, H.-E. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.018 · Cited by 81 · see citing works
Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80 · see citing works
Yamamoto, T., Kyo, M., Kamiya, T., Tanaka, T., Engel, J. D., Motohashi, H., & Yamamoto, M. P. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00965.x · Cited by 78 · see citing works
Sedlak, T. W., Nucifora, L. G., Koga, M., Shaffer, L. S., Higgs, C. P., Tanaka, T., Wang, A. M., Coughlin, J. M., Barker, P. B., Fahey, J. W., et al. (2017) · Complex Psychiatry · doi:10.1159/000487639 · Cited by 77 · see citing works
Honda, T., Yoshizawa, H., Sundararajan, C., David, E., Lajoie, M. J., Favaloro, F. G., Janosik, T., Su, X., Honda, Y., Roebuck, B. D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101445p · Cited by 71 · see citing works
Yang, B., Yang, C., Ren, Q., Zhang, J.-C., Chen, Q., Shirayama, Y., & Hashimoto, K. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0693-6 · Cited by 69 · see citing works
Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress
Zhang, J.-C., Yao, W., Dong, C., Han, M., Shirayama, Y., & Hashimoto, K. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0848-0 · Cited by 66 · see citing works
Lynch, R., Diggins, E., Connors, S. L., Zimmerman, A. W., Singh, K., Liu, H., Talalay, P., & Fahey, J. W. (2017) · Global Advances in Health and Medicine · doi:10.1177/2164957x17735826 · Cited by 59 · see citing works
Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress
Yang, C., Shirayama, Y., Zhang, J., Ren, Q., & Hashimoto, K. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.36 · Cited by 54 · see citing works
Yao, W., Zhang, J.-C., Dong, C., Zhuang, C., Hirota, S., Inanaga, K., & Hashimoto, K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.012 · Cited by 52 · see citing works
Dong, C., Zhang, J.-C., Yao, W., Ren, Q., Yang, C., Ma, M., Han, M., Saito, R., & Hashimoto, K. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.02.005 · Cited by 50 · see citing works
Matsuura, A., Ishima, T., Fujita, Y., Iwayama, Y., Hasegawa, S., Kawahara‐Miki, R., Maekawa, M., Toyoshima, M., Ushida, Y., Suganuma, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20538-3 · Cited by 48 · see citing works
Yang, M., Dang, R., Xu, P., Guo, Y., Han, W., Liao, D., & Jiang, P. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4949-x · Cited by 48 · see citing works
Mellon, S. H., Wolkowitz, O. M., Schonemann, M. D., Epel, E. S., Rosser, R., Burke, H. B., Mahan, L., Reus, V. I., Stamatiou, D., Liew, C. C., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.79 · Cited by 45 · see citing works
O’Connor, R. M., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.022 · Cited by 39 · see citing works
Lukić, I., Mitić, M., Djordjevic, J., Tatalović, N., Bozovic, N., Soldatović, I., Mihaljevic, M. M., Pavlović, Z., Radojcic, M. B., Marić, N. P., et al. (2014) · Neuropsychobiology · doi:10.1159/000362841 · Cited by 37 · see citing works
Li, S., Yang, C., Fang, X., Zhan, G., Huang, N., Gao, J., Xu, H., Hashimoto, K., & Luo, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00887 · Cited by 37 · see citing works
Yao, W., Zhang, J., Ishima, T., Ren, Q., Yang, C., Dong, C., Ma, M., Saito, A., Honda, T., & Hashimoto, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.037 · Cited by 29 · see citing works
Honda, T., Sundararajan, C., Yoshizawa, H., Su, X., Honda, Y., Liby, K. T., Sporn, M. B., & Gribble, G. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070141c · Cited by 28 · see citing works
Abuelezz, S. A., & Hendawy, N. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000335 · Cited by 28 · see citing works
Kostov, R. V., Knatko, E. V., McLaughlin, L. A., Henderson, C. J., Zheng, S., Huang, J. T.-J., Honda, T., & Dinkova‐Kostova, A. T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.016 · Cited by 26 · see citing works
Williams, B., & Dwyer, D. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06291.x · Cited by 18 · see citing works
Yu, C., Pan, S., Dong, M., & Niu, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.006 · Cited by 18 · see citing works
ω-3 and major depression: a review
de Mello, A. H., Gassenferth, A., de Souza, L. R., Fortunato, J. J., & Rezin, G. T. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.52 · Cited by 16 · see citing works
Releasing Nrf2 to promote neurite outgrowth
Rong, J., Yang, C., Cheng, Y., & Zhao, J. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.169618 · Cited by 10 · see citing works
Recent Advances in Nutrition for the Treatment of Depressive Disorder
Wang, X., Zhao, F., Wang, X., Niu, Y., Niu, L., & Wang, C. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180803113106 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
Arioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516 · see citing works
Nrf2: An all-rounder in depression
Zuo, C., Cao, H., Song, Y., Gu, Z., Huang, Y., Yang, Y., Miao, J., Zhu, L., Chen, J., Jiang, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102522 · Cited by 138 · see citing works
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 120 · see citing works
Yao, W., Lin, S., Su, J. Y., Cao, Q., Chen, Y., Chen, J., Zhang, Z., Hashimoto, K., Qi, Q., & Zhang, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01261-6 · Cited by 106 · see citing works
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
Hashimoto, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00036 · Cited by 95 · see citing works
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Attia, S. M., Bakheet, S. A., Ibrahim, K. E., Alqahtani, F., & Alqinyah, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.031 · Cited by 90 · see citing works
Dionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78 · see citing works
Guan, Y., Wang, J., Wu, X., Song, L., Wang, Y., Gong, M., & Li, B. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147661 · Cited by 57 · see citing works
He, L., Zheng, Y., Huang, L., Ye, J., Ye, Y., Luo, H., Chen, X., Yao, W., Chen, J., & Zhang, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02227-y · Cited by 57 · see citing works
Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity
Cao, Q., Zou, Q., Zhao, X. Y., Zhang, Y., Qu, Y., Wang, N., Murayama, S., Qi, Q., Hashimoto, K., Lin, S., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01063-9 · Cited by 47 · see citing works
Discovery of Eicosapentaenoic Acid Esters of Hydroxy Fatty Acids as Potent Nrf2 Activators
Gowda, S. G. B., Fuda, H., Tsukui, T., Chiba, H., & Hui, S. (2020) · Antioxidants · doi:10.3390/antiox9050397 · Cited by 45 · see citing works
Luo, K., Li, X., Wang, L., Rao, W., Wu, Y., Liu, Y., Pan, M., Huang, D., Zhang, W., & Mai, K. (2021) · Antioxidants · doi:10.3390/antiox10091449 · Cited by 43 · see citing works
Si, L., Xiao, L., Xie, Y., Xu, H., Yuan, G., Xu, W., & Wang, G. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.092 · Cited by 44 · see citing works
Liu, J., Fang, Y., Cui, L.-X., Wang, Z., Luo, Y., Gao, C., Ge, W., Huang, T., Wen, J., & Zhou, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112861 · Cited by 46 · see citing works
Cigliano, L., Spagnuolo, M. S., Boscaino, F., Ferrandino, I., Monaco, A., Capriello, T., Cocca, E., Iannotta, L., Treppiccione, L., Luongo, D., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900243 · Cited by 42 · see citing works
Qu, Y., Shan, J., Wang, S., Chang, L., Pu, Y., Wang, X., Tan, Y., Yamamoto, M. P., & Hashimoto, K. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01208-w · Cited by 42 · see citing works
Yoshino, Y., Roy, B., Kumar, N., Mukhtar, M. S., & Dwivedi, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01159-9 · Cited by 43 · see citing works
Xia, B., Liu, X., Li, X., Wang, Y., Wang, D., Kou, R.-W., Zhang, L., Shi, R., Ye, J., Bo, X., et al. (2022) · Food & Function · doi:10.1039/d1fo03888e · Cited by 41 · see citing works
Hashimoto, K. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1063-7 · Cited by 40 · see citing works
The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies
Sani, G., Margoni, S., Brugnami, A., Ferrara, O. M., Bernardi, E., Simonetti, A., Monti, L., Mazza, M., Janiri, D., Moccia, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12040817 · Cited by 41 · see citing works
Ji, Y., Luo, J., Zeng, J., Fang, Y., Liu, R., Luan, F., & Zeng, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643456 · Cited by 38 · see citing works
Fronza, M. G., Baldinotti, R., Fetter, J., Rosa, S. G., Sacramento, M., Nogueira, C. W., Alves, D. A. C., Praticò, D., & Savegnago, L. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.002 · Cited by 37 · see citing works
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33 · see citing works
Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice
Wang, M., Pu, D., Zhao, Y., Chen, J., Zhu, S., Lü, A., Liao, Z., Sun, Y., & Xiao, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117823 · Cited by 35 · see citing works
Fujita, Y., Fujita, A., Ishima, T., Hirai, A., Suzuki, S., Suganuma, H., & Hashimoto, K. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12112 · Cited by 33 · see citing works
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Bhandari, R., Kaur, J., Kaur, S., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1887141 · Cited by 32 · see citing works
Protective effects of sulforaphane against toxic substances and contaminants: A systematic review
Cascajosa-Lira, A., Prieto, A. I., Pichardo, S., Jos, A. M., & Cameán, A. M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155731 · Cited by 31 · see citing works
Ahmed, A., Misrani, A. A., Tabassum, S., Yang, L., & Long, C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.028 · Cited by 31 · see citing works
The compensatory antioxidant response system with a focus on neuroprogressive disorders
Morris, G., Puri, B. K., Walker, A. J., Berk, M., Walder, K. R., Bortolasci, C. C., Marx, W., Carvalho, A. F., & Maes, M. H. J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109708 · Cited by 31 · see citing works
Astaxanthin and Nrf2 Signaling Pathway: A Novel Target for New Therapeutic Approaches
Ashrafizadeh, M., Ahmadi, Z., Yaribeygi, H., Sathyapalan, T., & Sahebkar, A. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210505112834 · Cited by 30 · see citing works
The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis
Bugă, A. M., Pădureanu, V., Riza, A., Oancea, C. N., Albu, C. V., & Nica, A. D. (2023) · Cells · doi:10.3390/cells12141872 · Cited by 32 · see citing works
Luan, D., Zhao, M., Shi, Y., Li, L., Cao, Y.-J., Feng, H., & Zhang, Z. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i10.223 · Cited by 29 · see citing works
Park, J., Leem, Y., Park, J., Kim, D., Kang, J. L., & Kim, H.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084420 · Cited by 29 · see citing works
Wei, Y., Chang, L., Liu, G., Wang, X., Yang, Y. H., & Hashimoto, K. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109098 · Cited by 27 · see citing works
Musillo, C., Creutzberg, K. C., Collacchi, B., Ajmone‐Cat, M. A., Simone, R. D., Lepre, M., Amrein, I., Riva, M. A., Berry, A., & Cirulli, F. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02701-1 · Cited by 27 · see citing works
Nguyen, C. D., Yoo, J., Hwang, S., Cho, S.-Y., Kim, M., Jang, H., No, K. O., Shin, J. C., Kim, J., & Lee, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031193 · Cited by 27 · see citing works
Ma, L., Wang, L., Qu, Y., Wan, X., & Hashimoto, K. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02564-6 · Cited by 26 · see citing works
Subba, R., Ahmad, M. H., Ghosh, B., & Mondal, A. C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174993 · Cited by 25 · see citing works
Flazin as a Promising Nrf2 Pathway Activator
Fuda, H., Miyanaga, S., Furukawa, T., Umetsu, S., Joko, S., Roan, Y., Hirotaka, S., Hui, S., Watanabe, M., & Chiba, H. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04600 · Cited by 24 · see citing works
Coral-Pérez, S., Martínez-Martel, I., Martinez-Serrat, M., Batallé, G., Bai, X., Leite‐Panissi, C. R. A., & Pol, O. (2022) · Antioxidants · doi:10.3390/antiox11112153 · Cited by 23 · see citing works
Exploiting conjugated linoleic acid for health: a recent update
Chen, Y., Xiao, J., Zhu, X., Fan, X., Peng, M., Yang, M., Wang, C., Xia, L., & Zhou, M. (2024) · Food & Function · doi:10.1039/d4fo04911j · Cited by 21 · see citing works
Pu, Y., Chang, L., Qu, Y., Wang, S., Tan, Y., Wang, X., Zhang, J., & Hashimoto, K. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135032 · Cited by 19 · see citing works
Significant reduction of long non-coding RNAs expression in bipolar disorder
Maloum, Z., Taheri, M. N., Ghafouri‐Fard, S., & Shirvani-Farsani, Z. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03899-y · Cited by 19 · see citing works
Pu, Y., Qu, Y., Chang, L., Wang, S., Zhang, K., Ushida, Y., Suganuma, H., & Hashimoto, K. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12060 · Cited by 19 · see citing works
Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach
Kubick, N., Pajares, M., Enache, I., Manda, G., & Mickael, M. (2020) · Molecules · doi:10.3390/molecules25092155 · Cited by 18 · see citing works
Chen, Y., Xie, S.-Y., Chen, C., & Lu, D. (2021) · Molecular Brain · doi:10.1186/s13041-021-00860-0 · Cited by 19 · see citing works
Niu, Z., Wu, X., Zhu, Y., Yang, L., Shi, Y., Wang, Y., Qiu, H. X., Gu, W., Wu, Y., Long, X., et al. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00871-4 · Cited by 19 · see citing works
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18 · see citing works
Wang, X., Liu, J., Zhiping, D., & Sui, Y. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.007 · Cited by 18 · see citing works
Naß, J., Kampf, C. J., & Efferth, T. (2021) · Molecules · doi:10.3390/molecules26071827 · Cited by 17 · see citing works
Smaniotto, T. Â., Casaril, A. M., Lourenço, D. D. A., Sousa, F. S. S., Seixas, F. K., Collares, T. V., Woloski, R., Pinto, L. D. S., Alves, D. A. C., & Savegnago, L. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06336-4 · Cited by 17 · see citing works
He, L., Mo, X., He, L., Ma, Q., Cai, L., Zheng, Y., Huang, L., Lin, X., Wu, M.-S., Ding, W., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155332 · Cited by 17 · see citing works
The role of soluble epoxide hydrolase and its inhibitors in depression
Borsini, A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100325 · Cited by 16 · see citing works
Guo, Y., Huang, D., Pan, M., Yang, M., Luo, K., Liu, J., Wu, C., Zhang, W., & Mai, K. (2021) · Aquaculture Nutrition · doi:10.1111/anu.13339 · Cited by 14 · see citing works
Relationship Between Obesity and Depression Considering the Inflammatory Theory
Oracz, A. J., Zwierz, M., Naumowicz, M., Suprunowicz, M., & Waszkiewicz, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114966 · Cited by 14 · see citing works
Recinella, L., Chiavaroli, A., Orlando, G., Ferrante, C., Veschi, S., Cama, A., Marconi, G. D., Diomede, F., Gesmundo, I., Granata, R., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01228-5 · Cited by 14 · see citing works
Hashimoto, K. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01148-5 · Cited by 13 · see citing works
Hua, D., Luo, A., Wu, Z., Huang, C., Li, S., Xu, X., Xu, J., Yang, C., Wang, D., & Liu, C. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.005 · Cited by 13 · see citing works
Nguyen, C. D., Yoo, J., Jeong, S. J., Ha, H., Yang, J. H., Lee, G., Shin, J. C., & Kim, J. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01020-x · Cited by 12 · see citing works
Koszła, O., Kukula-Koch, W. A., Jóźwiak, K., Jastrząb, R., Marć, M. A., Mytych, J., Tabęcka-Łonczyńska, A., Skóra, B., Szychowski, K. A., & Sołek, P. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119393 · Cited by 11 · see citing works
Wang, B., Zhang, Q.-H., Li, X., Wang, S., Chen, X., Yu, B., & Liu, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113896 · Cited by 11 · see citing works
Suárez-Rojas, I., Pérez-Fernández, M., Bai, X., Martínez-Martel, I., Intagliata, S., Pittalà, V., Salerno, L., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12101859 · Cited by 11 · see citing works
Therapeutic Benefits of Saffron in Brain Diseases
Sharma, B., Kumar, H., Kaushik, P., Mirza, R., Awasthi, R., & Kulkarni, G. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818462-2.00010-3 · Cited by 11 · see citing works
Chen, J., Wei, Y., Li, N., Pi, C., Zhao, W., Zhong, Y., Li, W., Shen, H., Yang, Y., Zheng, W., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04363-6 · Cited by 8 · see citing works
Huang, X., Qu, Q., & Ren, D. (2021) · Inflammation · doi:10.1007/s10753-021-01554-4 · Cited by 8 · see citing works
Dai, X., Zhu, S., Ye, J., Xu, Q., Yi, T., Wu, C., Wang, B., Luo, K., & Gao, W. (2023) · Aquaculture Reports · doi:10.1016/j.aqrep.2023.101843 · Cited by 8 · see citing works
Khalaf, M. M., Mahmoud, H. M., Kandeil, M. A., Mahmoud, H. A., & Salama, A. (2024) · Drug and Chemical Toxicology · doi:10.1080/01480545.2024.2310641 · Cited by 8 · see citing works
Yang, Y. H., Eguchi, A., Mori, C., & Hashimoto, K. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.005 · Cited by 8 · see citing works
Li, Z., Liang, S., Cui, X., Shen, C., Xu, Z., Chen, W. J., Wu, M., Liang, C., Liu, J., Huang, J., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1414242 · Cited by 8 · see citing works
Luo, K., Shi, Y., Yang, K., Xu, Q., Jiang, Z., Gao, W., Wu, C., & Wang, Z. (2023) · Aquaculture Reports · doi:10.1016/j.aqrep.2023.101722 · Cited by 7 · see citing works
Yasuda, T., & Kashima, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27826 · Cited by 7 · see citing works
Mazzoli, A., Spagnuolo, M. S., Nazzaro, M., Porzio, A. D., Barrella, V., Troise, A. D., Pascale, S. D., Scaloni, A., Mauriello, G., Iossa, S., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106162 · Cited by 6 · see citing works
Chen, T., Yin, S., Yue, R., Pi, C., Zuo, Y., Jiang, Y., Zheng, W., Jiang, J., Yang, Y., Chu, S., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00600 · Cited by 6 · see citing works
Khiroya, K., Sekyere, E. O., McEwen, B. J., & Bayes, J. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000276 · Cited by 6 · see citing works
Gammoh, O., Akasheh, R. T., Qnais, E. Y., Altaber, S., Athamneh, R. Y., Hafiz, A. A., Alqudah, A. M., Aljabali, A. A. A., & Tambuwala, M. M. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01404-9 · Cited by 6 · see citing works
Fahey, L., & Lopez, L. M. (2024) · Genes, Brain and Behavior · doi:10.1111/gbb.70011 · Cited by 5 · see citing works
Zhang, W., Wu, Y., Guo, Y., Wang, C., Long, X., & Jiang, P. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.161 · Cited by 6 · see citing works
Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential
Shin, E., Nguyen, B.-T., Jeong, J. H., Nguyen, B.-C. H., Tran, N. K. C., Sharma, N., Kim, D.-J., Nah, S.-Y., Lichtstein, D., Nabeshima, T., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112657 · Cited by 5 · see citing works
Sterrett, J. D., Andersen, N. D., & Lowry, C. A. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_10 · Cited by 4 · see citing works
Qian, J., Nie, W., Zhang, Z., Fang, G., Li, C., & Li, W. (2025) · New Journal of Chemistry · doi:10.1039/d5nj02230d · Cited by 3 · see citing works
Mazaheri, E. L., Niknejad, A., Amini, E., & Nabiuni, M. (2023) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-141738 · Cited by 2 · see citing works
Cesare, B. D., Mancini, G. F., Lisiola, J. M., Pisaneschi, A., Sikora, V., Morena, M., Caraci, F., Riva, M. A., Schiavone, S., & Campolongo, P. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117413 · Cited by 2 · see citing works
Kalkman, H. O. (2021) · Psychiatry International · doi:10.3390/psychiatryint2010008 · Cited by 2 · see citing works
Potential Suicide Prophylactic Activity by the Fish Oil Metabolite, 4-Hydroxyhexenal
Kalkman, H. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136953 · Cited by 1 · see citing works
Nrf2 Dysregulation in Major Depressive and Bipolar Disorders
Hashemi, M., Ghanbarirad, M., Saberi, S. M., & Majd, A. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i.2074 · Cited by 1 · see citing works
Pan, M., Guo, Y., Huang, D., Ma, S., Li, X., Yang, M., Zhou, W., Mai, K., & Zhang, W. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.742013 · Cited by 1 · see citing works
Convolvulus pluricaulis usage and depression
Shah, P. D., & Gupta, G. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00001-5 · Cited by 1 · see citing works
Editorial: Resilience to stress-related mood disorders: Involvement of oxidative stress
Pesarico, A. P., Chagas, P. M., Rosa, S. G., & Budni, J. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1137682 · Cited by 1 · see citing works
Salama, A., Elhadidy, M. E., EL-Kassaby, M. I., & Farrag, A. R. H. (2022) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_53_21
Zhao, Y., Shen, L., Zhang, Y., Zhang, L., Jin, L., Chen, S., Song, C., Hu, C., & Liu, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-1003374/v1
Cirulli, F., Musillo, C., Kreutzberg, K., Collacchi, B., Ajmone‐Cat, M. A., Simone, R. D., Lepre, M., Amrein, I., Riva, M. A., & Berry, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2569163/v1
Fahey, L., & Lopez, L. M. (2024) · medRxiv · doi:10.1101/2024.02.16.24302920
Hwangbo, H., & Choi, Y. H. (2024) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2024.53.10.1021
A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation
Ishima, T., Osaka, H., Nagai, R., & Aizawa, K. (2025) · Antioxidants · doi:10.3390/antiox14050537
Pertiwi, M. S., Batubara, I., Fatriani, R., Wahyudi, S. T., Kusuma, W. A., Trivadila, T., & Priosoeryanto, B. P. (2025) · Natural Resources for Human Health · doi:10.53365/nrfhh/204979
Xu, D., Eguchi, A., Murayama, R., Liu, G., Zhao, M., Zhu, T., Cai, Y., Yue, Y., & Hashimoto, K. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110328
Iskakova, D. M., İlçe, B. Y., Kamzanova, A. T., Sitakanova, A., Hamoudi, R., & Kustubayeva, A. (2026) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2026.1904444
- Authors
- Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- ORCID
- Hashimoto, Kenji
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-16
- Volume
- 9
- Pages
- 1182-1182
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC6198170
- OpenAlex
- W2892958757
- Cited by
- 98
- References
- 106
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 14 · 2023: 14 · 2022: 19 · 2021: 24 · 2020: 10 · 2019: 8
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science London (17H04243)
- Japan Agency for Medical Research and Development (JP18dm0107119)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- Nrf2/Keap1 pathway, depression, mood disorders, neuroinflammation, inflammatory cytokines, BDNF/TrkB signaling, sulforaphane, glucoraphanin, cruciferous vegetables, chronic social defeat stress, learned helplessness, stress resilience, hippocampus, prefrontal cortex, major depressive disorder, bipolar disorder, antidepressant effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review